Stocks and Investing Stocks and Investing
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Ed Arce Maintained (AKBA) at Strong Buy with Increased Target to $6 on, Mar 28th, 2024


Published on 2024-10-28 09:59:10 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $5 to $6 on, Mar 28th, 2024.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $4 on, Wednesday, November 29th, 2023

Contributing Sources